Characterization of mouse mammary tumour virus-induced migration of lymphoid cells into lymph nodes. 2001

A Matsuzawa, and T Yasuda, and S Sakamoto, and H Nagase, and H Nakano, and T Yoshimoto
Laboratory Animal Research Centre, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo, Japan. atmatsu@oregano.ocn.ne.jp

We previously found that Mtv-2+ lymph nodes (LN) implanted into Mtv-2- mice underwent marked hyperplasia owing to the influx of lymphocytes. LN grafts infected with exogenous mouse mammary tumour viruses (MMTV), MMTV(FM) transmitted by FM mice and MMTV-2 produced by Mtv-2, also swelled in MMTV-free recipients. Mtv-3 and Mtv-7 also displayed this capability. Mtv-2-induced LN hyperplasia was earlier in onset and greater in extent when major histocompatibility complex (MHC) class II I-E was expressed than unexpressed. Mtv-3-induced LN hyperplasia was suppressed completely by Mtv-3 from a different mouse strain and partially by Mtv-6 slightly different from Mtv-3 in superantigen (SAg) Vbeta specificity. LN hyperplasia occurred bidirectionally in LN transplantation between mice carrying Mtv-2 and Mtv-3, which are different SAg Vbeta specificity. LN hyperplasia induced by MMTV-2 carrying SAg responsive to Vbeta14 alone and MMTV(FM) carrying SAg responsive to Vbeta14 and Vbeta8.2 was completely but partially suppressed by MMTV(FM) and MMTV-2, respectively. CD4+ T cells were essential for MMTV-induced LN hyperplasia. LN in situ also underwent significant hyperplasia when infected with MMTV. Thus, MMTV SAg may entice circulating lymphocytes into lymphoid organs and contribute to more efficient dissemination MMTV in vivo. Secondary lymphoid tissue chemokine (SLC) may not be directly involved in this event.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D008324 Mammary Tumor Virus, Mouse The type species of BETARETROVIRUS commonly latent in mice. It causes mammary adenocarcinoma in a genetically susceptible strain of mice when the appropriate hormonal influences operate. Bittner Virus,Mammary Cancer Virus,Mouse mammary tumor virus,Mammary Tumor Viruses, Mouse
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D005260 Female Females

Related Publications

A Matsuzawa, and T Yasuda, and S Sakamoto, and H Nagase, and H Nakano, and T Yoshimoto
November 1987, Gan no rinsho. Japan journal of cancer clinics,
A Matsuzawa, and T Yasuda, and S Sakamoto, and H Nagase, and H Nakano, and T Yoshimoto
August 1980, Immunology today,
A Matsuzawa, and T Yasuda, and S Sakamoto, and H Nagase, and H Nakano, and T Yoshimoto
June 1978, Journal of immunology (Baltimore, Md. : 1950),
A Matsuzawa, and T Yasuda, and S Sakamoto, and H Nagase, and H Nakano, and T Yoshimoto
April 1996, The Journal of general virology,
A Matsuzawa, and T Yasuda, and S Sakamoto, and H Nagase, and H Nakano, and T Yoshimoto
June 1969, Lymphology,
A Matsuzawa, and T Yasuda, and S Sakamoto, and H Nagase, and H Nakano, and T Yoshimoto
May 2012, Experimental hematology,
A Matsuzawa, and T Yasuda, and S Sakamoto, and H Nagase, and H Nakano, and T Yoshimoto
September 2006, Nature reviews. Immunology,
A Matsuzawa, and T Yasuda, and S Sakamoto, and H Nagase, and H Nakano, and T Yoshimoto
June 1984, The American journal of pathology,
A Matsuzawa, and T Yasuda, and S Sakamoto, and H Nagase, and H Nakano, and T Yoshimoto
June 1962, Nature,
Copied contents to your clipboard!